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Futility, in general, is the inability to achieve an intended goal or outcome. 
iomedical futility more specifically is a clinical judgment that, in light of the patient’s 
urrent clinical circumstance, it is not physiologically possible for an intervention to 
chieve its intended and predictable biomedical and therapeutic goals; therefore the 
roposed intervention would be medically ineffective.   
Traditionally physicians have been trained to unilaterally, and sometimes 
aternalistically, avoid treatment of untreatable diseases and to avoid harm by useless 
fforts.i    Decisions about when and how to treat patients who are “beyond hope” are 
uided by the physician’s skill and knowledge, and the benevolent precepts of the 
edical profession that require us to attend to the patient’s needs. Futility for the most 
art in the clinical setting has been objectively defined as “biomedical futility” by means 
f a unilateral appraisal of probably clinical outcome made by the physician and based on 
linical evidence, experience, and probability. 
The unilateral professional ability to make treatment decisions changed 
ramatically in the 1970s as patients began challenging physicians’ right to make 
ecisions unilaterally. Patients often now demand that they be the determiners of their 
wn fate. Futility began appearing in the medical literature as an ethical concern in the 
ate 1980s by which time the ability to sustain life in the face of serious and life 
hreatening illness had become much less limited.  Subsequently rapidly advancing 
evelopments in medical technology and the sophistication of intensive care units 
rovided the capability of keeping patients alive seemingly indefinitely.  In response, 
atients (as well as many physicians) began voicing concern that many patients were 
eing kept alive well beyond what they might consider to be a reasonable quality of 
xistence. ii iii  Futility, no longer defined solely by the physician in terms of medical 
uccess or failure, is now dependent on, and for the most part seems to be dominated by, 
atient preferences, values, and beliefs.  
The ability to delineate between “ordinary” and “extraordinary” treatments has 
lso become increasingly difficult for medical science. Continued medical advancement 
nd therapeutic success began to blur the ability to define biomedical futility because 
here has been no agreement in the medical community about underlying precepts that 
etermine futility.iv  From 1995 to 1999 the number of articles published in the medical 
iterature dealing with question of futility dwindled from 134 to 31, underscoring the 
eneral academic malaise arising in dealing with a question that seemingly could not be 
nswered.  Many physicians and theorists have argued that the concept of futility may be 
ndefinable and no longer pertinent in the modern paradigm of health care due to the 
apacity of modern medicine and the expectation of most patients to be treated.v 
Opposing this view is the belief that the very nature of illness and unavoidable death is 
universal and still requires consideration of values and beliefs of all stakeholders as 
objective criteria in determining if and when treatment is worthwhile.   
Medically ineffective treatment means that, to a reasonable degree of medical 
certainty, it is not possible for the proposed intervention to: 1) prevent or reduce the 
deterioration of the health of an individual; or 2) prevent the impending death of an 
individual; or 3) effectively or appreciably alter the course of disease. Biomedical futility 
per se does not take into consideration the beliefs and preferences of the patient, but it 
cannot avoid being influenced by the moral agency of the physician whose moral 
precepts are closely defined by their training and a sense of professional obligation to 
always treat disease.  A judgment that, though the intervention has a reasonable 
possibility of biomedical success, it should not be done because the quality of patient’s 
life would be poor, does not constitute biomedical futility under this definition. 
Hospital policies addressing futility and the withholding and withdrawing of 
treatment have been written, discussed, and implemented at MU Health Care, as they 
have in several other hospitals across the nation.vi  Futility policies such as these are 
intended for use by the clinician as guidelines for decision making about futile treatment.  
As with any hospital policy regarding patient care they should be utilized cautiously so as 
not to depersonalize decision making by removing it from the bedside or in any way 
erode the trust relationship that the patient has with her physician. 
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